% Expired Patents = 11.1

EPO Patents = 4

Trademarks = 14

Forward Citations = 4

Loading Chart...

10 inventors (with patents filed for the assignee):

Sun Kyo Lee (9 out of 9 patents)

Han Bong Ryu (8 out of 9 patents)

Seong Ran Lee (8 out of 11 patents)

4. Tae Hyun Kim (8 out of 87 patents)

5. Tae Won Choi (7 out of 10 patents)

6. Hyeong Il Kwon (4 out of 4 patents)

7. Jong Nam Choi (3 out of 3 patents)

8. Tae Hwa Jeong (2 out of 2 patents)

9. Woo Yeon Roh (1 out of 1 patent)

10. Je Geun Yoo (1 out of 1 patent)

9 patents: Sort by Forward Citations

1. 11986545 - Fusion protein comprising growth differentiation factor 11 and epidermal growth factor with enhanced anti-oxidation activity and enhanced skin cell proliferation effect and cosmetic composition for anti-wrinkle comprising the same as effective component (2024-05-21),

2. 11786450 - Fusion protein comprising heat shock protein 10 and brazzein protein with enhanced anti-oxidation activity and skin cell proliferation effect and anti-wrinkle cosmetic composition comprising the same as effective component (2023-10-17),

3. 11166898 - Human growth hormone fusion protein with enhanced thermal stability and cosmetic composition for anti-wrinkle and maintaining skin elasticity comprising the same as effective component (2021-11-09),

4. 10815284 - Fusion protein comprising antifreeze protein and human epidermal growth factor with increased anti-oxidant activity and skin cell proliferation effect and cosmetic composition for anti-wrinkle comprising the same as effective component (2020-10-27),

5. 10745451 - Scorpion toxin fusion protein with enhanced skin cell proliferation effect and cosmetic composition for anti-wrinkle, enhancing skin elasticity and anti-aging comprising the same as an effective ingredient (2020-08-18),

6. 10441632 - Anti-wrinkle and anti-aging cosmetic composition comprising green fluorescent protein-human epidermal growth factor fusion protein as effective component (2019-10-15),

7. 10266817 - Botulinum toxin-human epidermal growth factor fusion protein with increased skin cell proliferation and anti-oxidation effect and cosmetic composition for regenerating skin and improving skin wrinkle comprising the same as effective component (2019-04-23),

8. 10125181 - Thermostable human epidermal growth factor-spider venom fusion protein with increased skin cell proliferation effect and cosmetic composition for anti-wrinkle and maintaining elasticity of skin comprising the same as effective component (2018-11-13),

9. 9879060 - SV82 polypeptide, and cosmetic composition for reducing skin wrinkles and maintaining skin elasticity comprising SV82 polypeptide as active ingredient (2018-01-30),

Company Overview

Nexgen Biotechnologies, Inc. is a cutting-edge biotech company specializing in developing innovative solutions in the fields of bioengineering and molecular biology. With a focus on genetic manipulation and bioproduction, Nexgen is committed to advancing the future of healthcare, agriculture, and environmental sustainability through its groundbreaking research and products.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

9 Patents

#436 in Seoul

#1,188 in South Korea

Seoul, South Korea

Nexgen Biotechnologies, Inc.

Forward Citations = 4

10 inventors:

Sun Kyo Lee (9 out of 9 patents)

Han Bong Ryu (8 out of 9 patents)

Seong Ran Lee (8 out of 11 patents)

4. Tae Hyun Kim (8 out of 87 patents)

5. Tae Won Choi (7 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nexgen Biotechnologies, Inc.. Retrieved from https://idiyas.com/company/nexgen-biotechnologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]